Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression

被引:13
|
作者
Dou, Xiao-Lin [1 ]
Xia, Fa-Da [1 ]
Li, Xin-Ying [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Thyroid Surg, Changsha 410000, Hunan, Peoples R China
关键词
Thyroid carcinoma (TC); circ_0003747; MiR-338-3p; PLCD3; CELL-PROLIFERATION; INHIBITS APOPTOSIS; CIRCULAR RNA; CARCINOMA; MIGRATION;
D O I
10.1080/15592294.2023.2210339
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The circular RNAs (circRNAs) involved in competitive endogenous RNA (ceRNA) mechanism are critical modulators affecting pathogenesis of thyroid carcinoma (TC). The study's goal was to investigate the effects of circ 0003747 on the biological progression of papillary thyroid cancer (PTC). Normal thyroid cells Nthy-ori3-1 and TC derived cell lines were used in our study. Sanger sequencing and RNase R treatment were utilized for validating the circular structure of circ_0003747. In our work, circ_0003747 was found to be highly expressed in TC cells. Circ_0003747 knockdown reduced TC cell viability, proliferation, migration, and invasion while increasing cell apoptosis. Circ_0003747 targeted and negatively regulated miR-338-3p expression. Besides, miR-338-3p interacted with PLCD3 to repress its expression. Overexpression of miR-338-3p inhibited TC cell progression, and PLCD3 reversed these effects. Furthermore, PLCD3 overexpression reversed the effects of circ_0003747 knockdown on TC cells. Additionally, the knockdown of circ_0003747 remarkably suppressed tumour size and growth, restrained PLCD3 expression and promoted miR-338-3p expression in nude mice. In conclusion, circ_0003747 facilitated the biological progression of TC by modulating the miR-338-3p/PLCD3 axis, and it may be a new target for TC treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] CircASAP1 promotes the development of cervical cancer through sponging miR-338-3p to upregulate RPP25
    Feng, Lei
    Zhao, Manli
    Wu, Aihui
    ANTI-CANCER DRUGS, 2022, 33 (01) : E155 - E165
  • [2] has_circ_0070512 promotes prostate cancer progression by regulating the miR-338-3p/hedgehog signaling pathway
    Zhang, Pingxin
    Gao, Hang
    Yan, Ruping
    Yu, Lu
    Xia, Chengxing
    Yang, Delin
    CANCER SCIENCE, 2023, 114 (04) : 1491 - 1506
  • [3] The hsa_circ_0039857/miR-338-3p/RAB32 axis promotes the malignant progression of colorectal cancer
    Xu, Pei
    Cheng, Siying
    Wang, Xianwei
    Jiang, Shuming
    He, Xiaoyan
    Tang, Lina
    Wu, Ning
    Yang, Zhirong
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [4] The hsa_circ_0039857/miR-338-3p/RAB32 axis promotes the malignant progression of colorectal cancer
    Pei Xu
    Siying Cheng
    Xianwei Wang
    Shuming Jiang
    Xiaoyan He
    Lina Tang
    Ning Wu
    Zhirong Yang
    BMC Gastroenterology, 22
  • [5] Circ_0124208 Promotes the Progression of Hepatocellular Carcinoma by Regulating the miR-338-3p/LAMC1 Axis
    Chen, Jianyu
    Liu, Zhi
    Zhong, Yang
    Chen, Hui
    Xie, Liang
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (11) : 1750 - 1763
  • [6] Circ_0124208 Promotes the Progression of Hepatocellular Carcinoma by Regulating the miR-338-3p/LAMC1 Axis
    Jianyu Chen
    Zhi Liu
    Yang Zhong
    Hui Chen
    Liang Xie
    Molecular Biotechnology, 2023, 65 : 1750 - 1763
  • [7] Circ_0058063 promotes progression of thyroid cancer by sponging miR-330-3p/SDC4 axis
    Tang, Mingwei
    Wang, Fengbo
    Wang, Ke
    Jiang, Yuan
    Wang, Qiongfen
    ANTI-CANCER DRUGS, 2022, 33 (07) : 642 - 651
  • [8] RETRACTED: Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p (Retracted Article)
    Zhang, Li
    Ding, Fengping
    ONCOTARGETS AND THERAPY, 2019, 12 : 6577 - 6589
  • [9] CircTIAM1 overexpression promotes the progression of papillary thyroid cancer by regulating the miR-338-3p/LASP1 axis
    Zhang, Ye
    Liang, Yanan
    Wu, Yan
    Song, Liwen
    Zhang, Zuwang
    ONCOLOGY RESEARCH, 2024, 32 (11) : 1747 - 1763
  • [10] HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression
    Li, Weizhi
    Xue, Hui
    Li, Yingchao
    Li, Peijie
    Ma, Fuquan
    Liu, Mengying
    Kong, Shuzhen
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (10) : 3439 - 3447